Carfilzomib

(2S)-4-methyl-N-[(1S)-1-{[(2S)-4-methyl-1-[(2R)-2-methyloxiran-2-yl]-1-oxopentan-2-yl]carbamoyl}-2-phenylethyl]-2-[(2S)-2-[2-(morpholin-4-yl)acetamido]-4-phenylbutanamido]pentanamide

72X6E3J5AR

868540-17-4

Carfilzomib

[Wiki]

carfilzomib

carfilzomib

carfilzomibum

Kyprolis

L-Phenylalaninamide, N-[(2S)-2-[[2-(4-morpholinyl)acetyl]amino]-1-oxo-4-phenylbutyl]-L-leucyl-N-[(1S)-3-methyl-1-[[(2R)-2-methyloxiranyl]carbonyl]butyl]-

N-[(2S)-2-{[2-(4-Morpholinyl)acétyl]amino}-4-phénylbutanoyl]-L-leucyl-N-{(2S)-4-méthyl-1-[(2R)-2-méthyl-2-oxiranyl]-1-oxo-2-pentanyl}-L-phénylalaninamide

N-{(2S)-2-[(4-Morpholinylacetyl)amino]-4-phenylbutanoyl}-L-leucyl-N-{(2S)-4-methyl-1-[(2R)-2-methyl-2-oxiranyl]-1-oxo-2-pentanyl}-L-phenylalaninamid

N-{(2S)-2-[(4-Morpholinylacetyl)amino]-4-phenylbutanoyl}-L-leucyl-N-{(2S)-4-methyl-1-[(2R)-2-methyl-2-oxiranyl]-1-oxo-2-pentanyl}-L-phenylalaninamide

(2S)-4-methyl-N-[(1S)-2-[[(1S)-3-methyl-1-[(2R)-2-methyloxirane-2-carbonyl]butyl]amino]-2-oxo-1-(phenylmethyl)ethyl]-2-[[(2S)-2-[(2-morpholinoacetyl)amino]-4-phenyl-butanoyl]amino]pentanamide

(2S)-4-methyl-N-[(1S)-2-[[(1S)-3-methyl-1-[[(2R)-2-methyl-2-oxiranyl]-oxomethyl]butyl]amino]-2-oxo-1-(phenylmethyl)ethyl]-2-[[(2S)-2-[(2-morpholino-1-oxoethyl)amino]-1-oxo-4-phenylbutyl]amino]pentanamide(2S)-N-[(1S)-1-(benzyl)-2-keto-2-[[(1S)-3-methyl-1-[(2R)-2-methyloxirane-2-carbonyl]butyl]amino]ethyl]-4-methyl-2-[[(2S)-2-[(2-morpholinoacetyl)amino]-4-phenyl-butanoyl]amino]valeramide

(2S)-4-methyl-N-[(2S)-1-[[(2S)-4-methyl-1-[(2R)-2-methyl-2-oxiranyl]-1-oxopentan-2-yl]amino]-1-oxo-3-phenylpropan-2-yl]-2-[[(2S)-2-[[2-(4-morpholinyl)-1-oxoethyl]amino]-1-oxo-4-phenylbutyl]amino]pentanamide

(2S)-4-methyl-N-[(2S)-1-[[(2S)-4-methyl-1-[(2R)-2-methyloxiran-2-yl]-1-oxo-pentan-2-yl]amino]-1-oxo-3-phenyl-propan-2-yl]-2-[[(2S)-2-(2-morpholin-4-ylethanoylamino)-4-phenyl-butanoyl]amino]pentanamide

(2S)-4-methyl-N-[(2S)-1-[[(2S)-4-methyl-1-[(2R)-2-methyloxiran-2-yl]-1-oxopentan-2-yl]amino]-1-oxo-3-phenylpropan-2-yl]-2-[[(2S)-2-[(2-morpholin-4-ylacetyl)amino]-4-phenylbutanoyl]amino]pentanamide

(Alphas)-alpha-((4-morpholinylacetyl)amino)benzenebutanoyl-l-leucyl-n-((1s)-3-methyl-1-(((2r)-2-methyloxiranyl)carbonyl)butyl)-l-phe nylalaninamide

(aS)-a-[(4-Morpholinylacetyl)amino]benzenebutanoyl-L-leucyl-N-[(1S)-3-methyl-1-[[(2R)-2-methyloxiranyl]carbonyl]butyl]-L-phenylalaninamide

(S)-4-Methyl-N-((S)-1-(((S)-4-methyl-1-((R)-2-methyloxiran-2-yl)-1-oxopentan-2-yl)amino)-1-oxo-3-phenylpropan-2-yl)-2-((S)-2-(2-morpholinoacetamido)-4-phenylbutanamido)pentanamide

(αS)-α-[[2-(4-Morpholinyl)acetyl]amino]benzenebutanoyl-L-leucyl-N-[(1S)-3-methyl-1-[[(2R)-2-methyl-2-oxiranyl]carbonyl]butyl]-L-phenylalaninamide

1537187-53-3

1960444-12-5

95%

Carfilzomib (PR171)

carfilzomib(pr-171)

carfilzomib(pr171)

carfilzomib-d8

carfilzomibum

Kyprolis®

L01XX

MFCD11040997

MFCD28142641

N-{(2S)-2-[(morpholin-4-ylacetyl)amino]-4-phenylbutanoyl}-L-leucyl-N-{(2S)-4-methyl-1-[(2R)-2-methyloxiran-2-yl]-1-oxopentan-2-yl}-L-phenylalaninamide

PR 171;PR171;PR-171

Proteasome subunit beta type-1

Proteasome subunit beta type-10

Proteasome subunit beta type-2

Proteasome subunit beta type-5

Proteasome subunit beta type-6

Proteasome subunit beta type-7

Proteasome subunit beta type-8

Proteasome subunit beta type-9

PSB10_HUMAN

PSB1_HUMAN

PSB2_HUMAN

PSB5_HUMAN

PSB6_HUMAN

PSB7_HUMAN

PSB8_HUMAN

PSB9_HUMAN

β-secretaseinhibitoriii

карфилзомиб

كارفيلزوميب

卡非佐米